In other recent news, Recursion Pharmaceuticals reported its fourth-quarter 2025 earnings, delivering results that surpassed expectations. The company posted an earnings per share (EPS) of -$0.21, ...

Ami Nakai of Japan performs during the Women's Single Skating Short Program at the Milano Cortina 2026 Winter Olympic Games in Milan, Italy, on February 17, 2026. Senior Correspondent If there is one ...

The Blade Angels have one shot at reaching heaven. Arriving at the 2026 Milan Cortina Olympics with a tight-knit trio that ranked among the most talented contingents in American figure skating history ...

Amber Glenn earned zero points in a category for an “invalid element” after failing to do a triple loop. | Geoff Burke-Imagn Images Amber Glenn lost major points in her short program routine on ...

Editor's note: Alysa Liu won Olympic gold in women's figure skating. MILAN — The night started with promise and hope for the U.S. women's figure skating team. The trio of "Blade Angels" — close ...

Glenn, 26, missed her triple toe loop partway through her program, invalidating the element Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything from the NFL to tennis to Simone ...

The "Quad God" is also pretty good at backflips. U.S. figure skating star Ilia Malinin-- who dubbed himself "Quad God" for his ability to land the quadruple axel -- made his debut at at the 2026 Milan ...

WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to participate in its PreCheck pilot program, designed to boost domestic drug supply by speeding ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the overlooked penny stocks to invest in. On January 12, Alec Stranahan, an analyst at Bank of America Securities, maintained a Hold rating on ...

As Hoosiers ring in 2026, three major initiatives have been announced for the new year, two related to the SNAP program and one addressing disparities in rural health. Hoosiers who use Supplemental ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...